Phase 2 Study of Apatinib, a Novel VEGFR Inhibitor in Patients With Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Head and Neck: Preliminary Results

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.12.184
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma

Oral Oncology
Cancer ResearchOral SurgeryOncology
2013English

Adenoid Cystic Carcinoma of Seromucous Glands of the Head and Neck

Plastic and Reconstructive Surgery
Surgery
1963English

A Study of Adenoid Cystic Carcinoma of the Head and Neck in the Shinshu University Hospital

Practica Otologica, Supplement
Otorhinolaryngology
1999English

Histopathological Studies on Adenoid Cystic Carcinoma in the Region of Head and Neck

Japanese jornal of Head and Neck Cancer
1989English

Clinical Trial of Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck: A Multicenter Phase 2 Study (Korean Cancer Study Group HN14-01)

Cancer
Cancer ResearchOncology
2017English

Postoperative Intensity-Modulated Proton Therapy for Head and Neck Adenoid Cystic Carcinoma

International Journal of Particle Therapy
Nuclear MedicineRadiologyMolecular Physics,ImagingOpticsAtomic
2016English

Adenoid Cystic Carcinoma of the Head and Neck Area: Oncologic Treatment and Plastic-Reconstructive Options

Ear, Nose and Throat Journal
MedicineOtorhinolaryngology
2017English

A Case Report of Successful Treatment of Metastatic Gastral Neuroendocrine Carcinoma to a Small-Molecule VEGFR-2 Tyrosine Kinase Inhibitor Apatinib

Biomedical Research
2018English

Pcn105 - Economic Burden of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy